Literature DB >> 21160738

Ultra-high-field magnetic resonance: Why and when?

Ewald Moser1.   

Abstract

This paper briefly summarizes the development of magnetic resonance imaging and spectroscopy in medicine. Aspects of magnetic resonancephysics and -technology relevant at ultra-high magnetic fields as well as current limitations are highlighted. Based on the first promising studies, potential clinical applications at 7 Tesla are suggested. Other aims are to stimulate awareness of the potential of ultra-high field magnetic resonance and to stimulate active participation in much needed basic or clinical research at 7 Tesla or higher.

Keywords:  Alzheimer’s disease; Brain tumors; Cartilage; Functional magnetic resonance imaging; Magnetic resonance; Magnetic resonance spectroscopy; Multiple sclerosis; Ultra-high field magnetic resonance methods

Year:  2010        PMID: 21160738      PMCID: PMC2999312          DOI: 10.4329/wjr.v2.i1.37

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  31 in total

1.  Analysis of wave behavior in lossy dielectric samples at high field.

Authors:  Qing X Yang; Jinghua Wang; Xiaoliang Zhang; Christopher M Collins; Michael B Smith; Haiying Liu; Xiao-Hong Zhu; J Thomas Vaughan; Kamil Ugurbil; Wei Chen
Journal:  Magn Reson Med       Date:  2002-05       Impact factor: 4.668

2.  3.0 Tesla MR systems.

Authors:  Ewald Moser; Siegfried Trattnig
Journal:  Invest Radiol       Date:  2003-07       Impact factor: 6.016

3.  High-field MRI of brain cortical substructure based on signal phase.

Authors:  Jeff H Duyn; Peter van Gelderen; Tie-Qiang Li; Jacco A de Zwart; Alan P Koretsky; Masaki Fukunaga
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

Review 4.  Magnetic resonance imaging methodology.

Authors:  Ewald Moser; Andreas Stadlbauer; Christian Windischberger; Harald H Quick; Mark E Ladd
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

5.  Time-of-flight magnetic resonance angiography at 7 Tesla.

Authors:  Johannes T Heverhagen; Eric Bourekas; Steffen Sammet; Michael V Knopp; Petra Schmalbrock
Journal:  Invest Radiol       Date:  2008-08       Impact factor: 6.016

6.  MR imaging of the human hand and wrist at 7 T.

Authors:  Björn Behr; Jörg Stadler; Henrik J Michaely; Hans-Georg Damert; Wolfgang Schneider
Journal:  Skeletal Radiol       Date:  2009-03-10       Impact factor: 2.199

7.  Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results.

Authors:  Andreas Deistung; Alexander Rauscher; Jan Sedlacik; Jörg Stadler; Stephan Witoszynskyj; Jürgen R Reichenbach
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

8.  Ultra high field MR: useful instruments or toys for the boys.

Authors:  Jürgen Hennig
Journal:  MAGMA       Date:  2008-03       Impact factor: 2.310

9.  Sodium-23 magnetic resonance brain imaging.

Authors:  S S Winkler
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

10.  Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy.

Authors:  Martin Meyerspeer; Graham J Kemp; Vladimir Mlynárik; Martin Krssák; Julia Szendroedi; Peter Nowotny; Michael Roden; Ewald Moser
Journal:  Magn Reson Med       Date:  2007-04       Impact factor: 4.668

View more
  13 in total

1.  Aqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging.

Authors:  Matthew J Allen
Journal:  Synlett       Date:  2016-06       Impact factor: 2.454

2.  Interaction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance Imaging.

Authors:  Joel Garcia; Matthew J Allen
Journal:  Inorganica Chim Acta       Date:  2012-07-20       Impact factor: 2.545

3.  Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

Authors:  Joel Garcia; Jaladhar Neelavalli; E Mark Haacke; Matthew J Allen
Journal:  Chem Commun (Camb)       Date:  2011-11-02       Impact factor: 6.222

4.  MRI estimation of gadolinium and albumin effects on water proton.

Authors:  Hassan Bagher-Ebadian; Ramesh Paudyal; Tavarekere N Nagaraja; Richard L Croxen; Joseph D Fenstermacher; James R Ewing
Journal:  Neuroimage       Date:  2010-05-20       Impact factor: 6.556

Review 5.  Functional brain imaging in neuropsychology over the past 25 years.

Authors:  David R Roalf; Ruben C Gur
Journal:  Neuropsychology       Date:  2017-11       Impact factor: 3.295

Review 6.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616

7.  Synthesized tissue-equivalent dielectric phantoms using salt and polyvinylpyrrolidone solutions.

Authors:  Carlotta Ianniello; Jacco A de Zwart; Qi Duan; Cem M Deniz; Leeor Alon; Jae-Seung Lee; Riccardo Lattanzi; Ryan Brown
Journal:  Magn Reson Med       Date:  2017-11-20       Impact factor: 4.668

8.  Windows on the human body--in vivo high-field magnetic resonance research and applications in medicine and psychology.

Authors:  Ewald Moser; Martin Meyerspeer; Florian Ph S Fischmeister; Günther Grabner; Herbert Bauer; Siegfried Trattnig
Journal:  Sensors (Basel)       Date:  2010-06-08       Impact factor: 3.576

9.  Semi-LASER localized dynamic 31P magnetic resonance spectroscopy in exercising muscle at ultra-high magnetic field.

Authors:  Martin Meyerspeer; Tom Scheenen; Albrecht Ingo Schmid; Thomas Mandl; Ewald Unger; Ewald Moser
Journal:  Magn Reson Med       Date:  2011-03-07       Impact factor: 4.668

10.  Comparing localized and nonlocalized dynamic 31P magnetic resonance spectroscopy in exercising muscle at 7 T.

Authors:  Martin Meyerspeer; Simon Robinson; Christine I Nabuurs; Tom Scheenen; Adrian Schoisengeier; Ewald Unger; Graham J Kemp; Ewald Moser
Journal:  Magn Reson Med       Date:  2012-02-14       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.